Andreas Halvorsen - Viking Global Investors
Holding/activity history for Intellia Therapeutics Inc (NTLA)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2023 Q2 | 0 | 0.00 | Sell 100.00% | 0.28 | SEC | ||
| 2023 Q1 | 1,569,545 | 0.28 | Reduce 22.35% | 0.08 | $37.27 | $58,496,942 | SEC |
| 2022 Q4 | 2,021,410 | 0.35 | Add 7.01% | 0.02 | $34.89 | $70,526,995 | SEC |
| 2022 Q3 | 1,889,067 | 0.49 | Reduce 15.23% | 0.08 | $55.96 | $105,712,000 | SEC |
| 2022 Q2 | 2,228,383 | 0.53 | Reduce 9.74% | 0.07 | $51.76 | $115,341,000 | SEC |
| 2022 Q1 | 2,468,760 | 0.73 | Add 56.30% | 0.26 | $72.67 | $179,405,000 | SEC |
| 2021 Q4 | 1,579,536 | 0.54 | Add 23.45% | 0.10 | $118.24 | $186,764,000 | SEC |
| 2021 Q3 | 1,279,531 | 0.48 | Add 31.22% | 0.11 | $134.15 | $171,649,000 | SEC |
| 2021 Q2 | 975,092 | 0.48 | Buy | 0.48 | $161.91 | $157,877,000 | SEC |